🇺🇸 FDA
Patent

US 10766858

Substituted benzamides and methods of use thereof

granted A61PA61P25/04

Quick answer

US patent 10766858 (Substituted benzamides and methods of use thereof) held by Xenon Pharmaceuticals Inc. expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P25/04